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ABSTRACT 11 
Interferon-gamma has been typically described as a pro-inflammatory cytokine playing 12 
an important role in the resolution of both viral and bacterial diseases. Nevertheless, 13 
some anti-inflammatory functions are also attributed to this molecule. In this work we 14 
have characterized for the first time the turbot (Scophthalmus maximus) interferon-15 
gamma gene (ifng) and its expression pattern under basal conditions, after type I IFNs 16 
administration, and viral and bacterial infection. The intramuscular injection of an 17 
expression plasmid encoding turbot Ifng (pMCV1.4-ifng) was not able to affect the 18 
transcription of numerous immune genes directly related to the activity of IFN-gamma, 19 
with the exception of macrophage-colony stimulating factor (csf1). It was also unable to 20 
reduce the mortality caused by a Viral Hemorrhagic Septicemia Virus (VHSV) or 21 
Aeromonas salmonicida challenge. Interestingly, at 24 hours post-infection, turbot 22 
previously inoculated with pMCV1.4-ifng and infected with VHSV showed an increase 23 
in the expression of pro-inflammatory cytokines and type I IFNs compared to those fish 24 
not receiving expression plasmid, indicating a synergic effect of Ifng and VHSV. On the 25 
other hand, some macrophage markers, such as the macrophage receptor with 26 
collagenous structure (marco), were down-regulated by Ifng during the viral infection. 27 
Ifng had the opposite effect in those turbot infected with the bacteria, showing a 28 
reduction in the transcription of pro-inflammatory and type I IFNs genes, and an 29 
increase in the expression of genes related to the activity of macrophages.   30 
 31 
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1. Introduction 34 
Interferons (IFNs) are a family of multifunctional cytokines with central 35 
importance against viral infections, among other immune functions [1]. These proteins 36 
are produced when a pathogen is detected by the pattern recognition receptors (PRRs), 37 
which results in the activation of different signaling pathways [2]. In fish, two 38 
subfamilies of IFNs were established in basis to differential structural and functional 39 
properties, type I and type II IFNs [3]. Type I IFN subfamily comprises a group of 40 
typical antiviral proteins, and a variable number of type I IFNs were described in 41 
several teleost species [3]. Indeed, it has been shown that type I IFNs from the same 42 
teleost can possess distinct properties and capabilities, suggesting in some cases 43 
complementary or specialized roles, as was previously observed in turbot [4]. In 44 
contrast, IFN-gamma (type II IFN) is a markedly different IFN, possessing some ability 45 
to interfere with viral infections but being mainly an immunomodulatory molecule 46 
[5,6]. This cytokine is produced by diverse immune-related cell types, although T and 47 
NK cells are the major sources, and it is implicated in several aspects of the immunity, 48 
such as activation of macrophages, stimulation of antigen presentation, orchestration of 49 
leukocyte-endothelium interactions, and effects on cell proliferation and apoptosis, 50 
among others [7]. Regarding inflammation, IFN-gamma was typically described as a 51 
pro-inflammatory protein, although this appreciation seems to not be totally absolute 52 
because, in some cases, protective anti-inflammatory functions were related with this 53 
cytokine [8,9]. 54 
Unlike mammals, it has been shown that some bony fish, especially cyprinids, 55 
possess two type II interferon genes [10-14]. A teleost-specific duplication of the ifng 56 
gene originated the additional IFN-gamma related (ifngrel) gene, although it is not a 57 
clear homologue of mammalian IFN-gamma [3]. The inflammatory functions of teleost 58 
type II IFNs have not been fully characterized, especially in the case of those species 59 
possessing two genes. Some studies revealed that Ifng has the ability to induce the 60 
expression of pro-inflammatory cytokines [15-17]. Nevertheless, it was reported that 61 
zebrafish Ifng lacks the powerful pro-inflammatory activity of its mammalian 62 
counterpart, although it helped to potentiate the induction of antiviral and pro-63 
inflammatory genes by type I IFNs [18].  It was observed that, as in mammals, fish Ifng 64 
induces the activation of phagocytic cells by increasing the production of reactive 65 
oxygen intermediates (ROIs) and nitric oxide (NO), the enhancement of phagocytosis 66 
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and the up-regulation in the expression of different immune genes in this cell type 67 
[13,16,17,19]. 68 
Exploring the turbot genome [20], we found only one type II IFN gene, 69 
corresponding to ifng. To get insights into its functions, we analyzed its constitutive 70 
expression and gene modulation after viral and bacterial challenge, as well as its 71 
induction by type I IFNs. The bioactivity of turbot Ifng was measured by analyzing its 72 
protection capabilities against infections and the induction of specific immune-related 73 
genes in vivo. Although no protection was observed against bacterial or viral infections, 74 
our results showed the dual role of turbot Ifng in the expression of immune genes 75 
depending on the pathogen. Ifng seemed to synergistically induce inflammation and 76 
type I IFN synthesis upon viral infection, but a reduction in macrophage-related 77 
molecules was observed. Strikingly, the opposite effect was observed during the 78 
infection with bacteria. 79 
 80 
2. Material and Methods 81 
2.1. Characterization of turbot Ifng 82 
The complete sequence of the ifng gene was retrieved from the turbot genome project 83 
[20]. The open reading frame (ORF) was confirmed by PCR using specific primers and 84 
subsequent linking into pCR™2.1-TOPO® vector (Invitrogen) for its cloning using One 85 
Shot
®
 TOP10F´ competent cells (Invitrogen) following the protocol instructions. cDNA 86 
sequencing was conducted using an automated ABI 3730 DNA Analyzer (Applied 87 
Biosystems, Inc. Foster City, CA, USA). The primers used for ORF confirmation are 88 
listed in Supplementary Data Table 1. The presence of interferon-gamma activated sites 89 
(GAS) and interferon-stimulated response elements (ISRE) was analyzed in the 90 
promoter region using the canonical sequences TT(C/A)CNNNAA(A/G) and 91 
(G/A)(G/A)AANNGAAA(C/G), respectively. 92 
The presence of signal peptide was analyzed with the SignalP 3.0 Server 93 
(http://www.cbs.dtu.dk/services/signalp-3.0/) [21] and the nuclear localization signal 94 
(NLS) was determined using NLStradamus 95 
(http://www.moseslab.csb.utoronto.ca/NLStradamus/) [22]. Molecular weight and 96 
isoelectric point were calculated using the Compute pI/Mw tool from ExPASy [23]. The 97 
5 
 
3D-structure of turbot Ifng was predicted using I-TASSER server [24] selecting the 98 
model with the best C-score and viewed by PyMOL (http://www.pymol.org). The 99 
Template Modelling Score (TM-score), a measure of structural similarity between two 100 
proteins, was also considered in order to identify those structural analogs with known 101 
crystal architecture in the Protein Data Bank (PDB; http://www.rcsb.org/pdb/). 102 
2.2. Phylogenetic analysis 103 
IFN-gamma and IFN-gamma-related protein sequences from representative species 104 
were retrieved from Genbank (Supplementary Data Table 2). MAFFT online server was 105 
used to generate a starting alignment following the E-INS-i strategy [25], which was 106 
pruned using Gblocks server 0.91b [26]. The best-fitting amino acid replacement model 107 
was determined using ProtTest 3.2 [27] based on the Akaike Information Criterion 108 
(AIC) [28]. Finally, the maximum likelihood gene tree was estimated with PhyML 3.0 109 
[29]. Nodal confidence was calculated using 1000 non-parametric bootstrap replicates 110 
and represented in a 100 scale in FigTree v1.3.1 [30] 111 
(http://tree.bio.ed.ac.uk/software/figtree/). 112 
2.3. Fish, virus, bacteria 113 
Juvenile turbot (average weight 2.5 g) were obtained from a commercial fish farm 114 
(Insuiña S.L., Galicia, Spain). Animals were maintained in 500 L fibreglass tanks with a 115 
re-circulating saline water system (total salinity about 35 g/L) with a light-dark cycle of 116 
12:12 h at 18 °C and fed daily with a commercial dry diet (LARVIVA-BioMar). Prior 117 
to experiments, fish were acclimatized to laboratory conditions for 2 weeks. Fish care 118 
and challenge experiments were reviewed and approved by the CSIC National 119 
Committee on Bioethics under approval number 151-2014. 120 
Viral Hemorrhagic Septicemia Virus (VHSV) strain UK-860/94 was propagated in EPC 121 
(Epithelioma Papulosum Cyprini) cells using Eagle’s minimum essential medium 122 
(MEM) supplemented with 2% fetal bovine serum (FBS), penicillin and streptomycin 123 
(P/S) at 15 °C. The second passage was stored at -80 °C until use. 124 
Aeromonas salmonicida subsp. salmonicida (strain VT 45.1 WT) was cultured in tryptic 125 
soy agar (TSA) plates at 22 ºC during 24 h before being used.  126 
2.4. Expression plasmid pMCV1.4-ifng 127 
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The expression plasmid encoding the turbot Ifng, pMCV1.4-ifng, was produced using 128 
the nucleotide sequence encoding the Ifng mature peptide. The expression (pMCV1.4-129 
ifng) and empty plasmid (pMCV1.4) were propagated using One Shot TOP10F´ 130 
competent E. coli cells (Invitrogen) and the purification was conducted using the 131 
PureLinkTM HiPure Plasmid Midiprep Kit (Invitrogen). The expression plasmids 132 
encoding turbot type I IFNs (pMCV1.4-ifn1 and pMCV1.4-ifn2) were previously 133 
produced in the same way [4]. 134 
2.5. ifng constitutive expression, induction by type I IFNs and modulation after 135 
viral and bacterial challenge.  136 
In order to examine the constitutive expression of ifng, eleven different tissues 137 
(peritoneal exudate cells – PEC–, blood, head kidney, trunk kidney, spleen, gill, liver, 138 
intestine, heart, brain, muscle) were obtained from 3 healthy fish (average weight 125  139 
g). After disinfecting the external surface of the fish with 70% ethyl alcohol, PEC were 140 
obtained by the injection of sterile PBS (500 µl) in the peritoneal cavity by using 1 ml 141 
syringes with a 25 gauge needle and, after massaging for 10 min, the cell suspensions 142 
were recovered. Blood samples were taken from the caudal vein by using a heparinized 143 
syringe. In both cases the samples were centrifuged at 1,500 g for 10 min and the 144 
supernatants were discarded. All the samples were processed for the analysis of ifng 145 
expression (section 2.7). 146 
Stimulations with the plasmids encoding two turbot type I IFNs (ifn1 and ifn2) were 147 
conducted by intramuscular (i.m.) injection in the region near the caudal peduncle by 148 
using 1 ml insulin syringes with a 30 gauge needle and positioned with a 45° insertion 149 
angle. Four groups of 6 turbot each were injected with a volume of 50 µl of one of the 150 
following treatments: 2.5 µg of pMCV1.4-ifn1, 2.5 µg of pMCV1.4-ifn2, 2.5 µg of 151 
pMCV1.4 (empty plasmid), and phosphate buffered saline (PBS) to the control group. 152 
At 48 h, the individuals were sacrificed and muscle (site of plasmid injection) and head 153 
kidney were sampled and processed for the analysis of ifng expression (section 2.7). 154 
Four groups, composed of 36 turbot/each, were intraperitoneally (i.p.) injected with 50 155 
µl of one of the following treatments: VHSV suspension (5 × 10
5
 TCID50/fish), A. 156 
salmonicida subsp. salmonicida suspension (5.5 × 10
5
 CFU/fish), viral medium 157 
(MEM+2% FBS+P/S) or PBS. The last two groups served as the control groups of the 158 
viral and bacterial infections, respectively. The head kidney from 12 individuals 159 
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belonging to each group was removed at different sampling points (8, 24 and 72 h), 160 
obtaining 4 pooled biological replicates (3 fish/replicate) that were processed for the 161 
analysis of ifng expression (section 2.7). 162 
2.6. Effect of pMCV1.4-ifng injection before and after pathogen challenge 163 
The protective ability of the intramuscular administration of the plasmid encoding Ifng 164 
was tested against VHSV and A. salmonicida. For the viral challenge, 160 fish were 165 
subdivided into 8 batches of 20 turbot each. Turbot from two tanks (two replicates per 166 
treatment) were then i.m. injected, in the same way as was done in the previous section, 167 
with a volume of 50 µl of one of the following treatments: 2.5 µg of pMCV1.4-ifng, 2.5 168 
µg of pMCV1.4 (empty plasmid) and PBS. After 2 days, the individuals were i.p. 169 
injected with a dose of VHSV of 5 × 10
5
 TCID50/fish. The two remaining groups were 170 
first i.m. inoculated with PBS and then i.p. with the viral medium and served as an 171 
absolute control (non-immunised and non-infected groups). The same experimental 172 
procedure was conducted with the Gram-negative bacterium A. salmonicida using a 173 
dose of 5 × 10
6
 CFU/ml and the corresponding control batches were i.p. injected with 174 
PBS. Replicate batches were placed alternatively in order to minimize the influence of 175 
tank position. Mortality was recorded over a period of 21 days. 176 
In parallel, 2 groups of 18 turbot were also injected with 2.5 µg of pMCV1.4-ifng or 177 
pMCV1.4. After 48 h, muscle (site of plasmid injection) and head kidney from 6 fish 178 
were sampled. Then, 6 fish from each batch were i.p. infected with VHSV and other 6 179 
with A. salmonicida. At 24 h post-challenge head kidney samples were taken (6 180 
individual samples). All these samples were processed for the analysis of gene 181 
expression (section 2.7). 182 
2.7. RNA extraction, cDNA synthesis and quantitative PCR analysis 183 
Total RNA from the different tissue samples was extracted using the Maxwell 16 LEV 184 
simplyRNA Tissue kit (Promega) with the automated Maxwell 16 Instrument in 185 
accordance with instructions provided by the manufacturer. The cDNA synthesis was 186 
performed with the SuperScript II Reverse Transcriptase (Invitrogen) using 0.5 µg of 187 
RNA.  188 
The expression profiles of ifng and genes related with the activity of Ifng, as well as the 189 
quantification of the VHSV glycoprotein or A. salmonicida, were determined using real-190 
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time quantitative PCR (qPCR). Specific qPCR primers for turbot genes were designed 191 
based on sequences obtained in a 454-pyrosequencing of turbot tissues [31] or in the 192 
turbot genome [20] by using the Primer3 program [32]. Primer sequences are listed in 193 
Supplementary data Table 1.  Their amplification efficiency was calculated using seven 194 
serial five-fold dilutions of head kidney cDNA from unstimulated turbot with the 195 
Threshold Cycle (CT) slope method [33] and the identity of the amplicons was 196 
confirmed by sequencing. Individual real-time PCR reactions were carried out in 25 µl 197 
reaction volume using 12.5 µl of SYBR GREEN PCR Master Mix (Applied 198 
Biosystems), 10.5 µl of ultrapure water (Sigma-Aldrich), 0.5 µl of each specific primer 199 
(10 µM) and 1 µl of five-fold diluted cDNA template in MicroAmp
 
optical 96-well 200 
reaction plates (Applied Biosystems). All reactions were performed using technical 201 
triplicates in a 7300 Real-Time PCR System thermocycler (Applied Biosystems) with 202 
an initial denaturation (95 °C, 10 min) followed by 40 cycles of a denaturation step (95 203 
°C, 15 s) and one hybridization-elongation step (60 °C, 1 min). Relative expression data 204 
were normalized using the eukaryotic translation elongation factor 1 alpha (eef1a) as 205 
reference gene, which is a good candidate for qPCR data normalization in fish and fish 206 
cell lines under infection conditions [34-37], and calculated using the Pfaffl method 207 
[33].  208 
2.8 Statistical analysis 209 
Expression results were represented graphically as the mean + the standard deviation of 210 
the biological replicates. In order to determine statistical differences, data were analyzed 211 
with the computer software package SPSS v.19.0 using the Student’s t-test.  212 
 213 
3. Results 214 
3.1. Characterization of the turbot ifng gene and protein analysis 215 
The complete coding region of turbot ifng, submitted to GenBank under accession 216 
number KX360748, consists of 609 bp encoding a protein of 202 amino acids (aa) 217 
(Figure 1A). The first 22 aa belong to the signal peptide and therefore, the mature 218 
peptide is composed by 180 residues, with a calculated molecular weight of 20.36 kDa 219 
and an isoelectric point of 10.25. Moreover, a nuclear localization signal was identified 220 
in the protein sequence. We also examined the tridimensional structure of the turbot 221 
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Ifng and, as expected due to its high structural similarity with human IFN-gamma (TM-222 
score = 0.741), it is mainly alpha helical (Figure 1B).  223 
As in other vertebrates, the genomic sequence turbot ifng is composed of 4 exons and 3 224 
introns. A detailed analysis of the promoter region (in a range of -1824 bp upstream) 225 
revealed that its expression is putatively regulated by three interferon-gamma activated 226 
sites (GAS) and one interferon-stimulated response element (ISRE) (Figure 1C). 227 
 228 
 229 
Figure 1. (A) Nucleotide and amino acid sequence of turbot ifng. The predicted signal peptide is underlined, whereas 230 
the nuclear localization signal (NLS) is boxed. (B) Comparison of the predicted tertiary structure of turbot Ifng (color 231 
cartoon view) with human IFN-gamma (blue ribbon diagram). (C) Promotor region of turbot ifng gene showing three 232 
potential GAS and one ISRE sequences. 233 
Concurring with the taxonomic classification, the phylogenetic analysis revealed that 234 
turbot Ifng was closely related to Ifng proteins from other flatfish species (Figure 2). 235 
Moreover, as was expected, Ifngrel proteins formed a separated cluster from the teleost 236 
Ifng ones. Nevertheless, teleost Ifng and Ifngrel appear more closely related between 237 
them than to vertebrate IFN-gamma proteins (Figure 2). 238 
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 239 
Figure 2. Phylogenetic tree showing the evolutionary relationships between vertebrate IFN-gamma and IFN-gamma 240 
related proteins. Only nodal bootstrap values lower than 95 are shown. 241 
3.2. Constitutive expression of ifng in different tissues and induction of its 242 
transcription 243 
The higher basal expression of turbot ifng was detected in PEC, followed by spleen 244 
(Figure 3). A similar expression level was observed in gill, trunk kidney and head 245 
kidney. The remaining tissues showed a lower ifng transcription.  246 
11 
 
 247 
Figure 3. Turbot ifng constitutive expression in different tissues obtained from healthy fish. 248 
The i.m. administration of the two expression plasmids encoding type I IFNs 249 
(pMCV1.4-ifn1 and pMCV1.4-ifn2), revealed that Ifn1 was able to significantly induce 250 
the expression of ifng both in muscle (Fold-Change = 2.5) and in head kidney (FC=3.4), 251 
whereas Ifn2 induced a significant increase only in the site of injection (FC=1.4) 252 
(Figure 4A). 253 
Notably, turbot ifng was highly modulated during viral and bacterial challenges (Figure 254 
4B). The i.p. injection of VHSV significantly induced the expression of this gene at 24 255 
(FC=233) and 72 hours post-infection (hpi) (FC=155). A. salmonicida challenge also 256 
induced significant modulation of ifng: higher expression was already detected early at 257 
8 hpi (FC=20.5), which decreased at 24 hpi (FC=4.2), and rose again to its highest 258 
expression at 72 hpi (FC=131).  259 
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 260 
Figure 4. (A) Induction of the expression of turbot ifng 2 days after the administration of the expression plasmids 261 
encoding both type I IFNs (pMCV1.4-ifn1 or pMCV1.4-ifn2) in muscle (site of injection) and head kidney or (B) at 262 
different sampling points after a VHSV or A. salmonicida challenge in head kidney samples.  Significant differences 263 
are displayed as ** (0.001<p<0.01), * (0.01<p<0.05). 264 
 265 
3.3. ifng expression plasmid (pMCV1.4-ifng) does not protect turbot against VHSV 266 
or A. salmonicida infection 267 
Local overexpression of ifng was induced with the i.m. injection of 2.5 µg of pMCV1.4-268 
ifng, and the increased expression was confirmed 48 hours post-inoculation (Figure 5A). 269 
Despite having a 470-fold higher expression of ifng than control individuals inoculated 270 
with the empty plasmid, pMCV1.4-ifng stimulated fish showed a similar pathogen 271 
proliferation during early infection stages and not significant differences were observed 272 
in the survival rates against VHSV (Figure 5B) and A. salmonicida (Figure 5C). 273 
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 274 
Figure 5. (A) Expression of turbot ifng in muscle (site of injection) 2 days after the administration of pMCV1.4-ifng 275 
compared to those individuals receiving the empty plasmid pMCV1.4. (B) Cumulative mortality (%) after a VHSV 276 
challenge in turbot previously injected in muscle with PBS, pMCV1.4 or pMCV1.4-ifng, and VHSV detection by 277 
qPCR in head kidney samples 24 h after infection. (C) Cumulative mortality (%) after an A. salmonicida challenge in 278 
turbot previously injected in muscle with PBS, pMCV1.4 or pMCV1.4-ifng, and bacteria detection by qPCR in head 279 
kidney samples 24 h after infection. 280 
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3.4. Pathogen-dependent role of Ifng in macrophage-related molecules expression, 281 
type I IFNs induction, and inflammation  282 
At 48 hours after the administration of the expression plasmid pMCV1.4-ifng, the 283 
modulation of sixteen immune-related genes typically related with the IFN-gamma 284 
activity was analyzed in head kidney samples by qPCR. Interestingly, only 285 
macrophage-colony stimulating factor (csf1) was found to be significantly 286 
overexpressed (FC=3.33) compared to the pMCV1.4-injected individuals (Figure 6).  287 
 288 
Figure 6. Expression analysis of several immune genes in head kidney samples 2 days after the i.m. injection of the 289 
expression plasmid pMCV1.4-ifng. Fold-changes were calculated by dividing the normalized expression values for 290 
the pMCV1.4-ifng inoculated turbot by the normalized expression values for the pMCV1.4- injected individuals 291 
(control group). Significant differences were displayed as * (p<0.05). 292 
Nevertheless, the most surprising results on the effect of ifng overexpression were 293 
observed during the viral and bacterial infections. VHSV challenge (pMCV1.4 – 294 
VHSV) significantly induced the expression of several immune-related genes compared 295 
to non-infected fish: pyd and card domain containing (asc), caspase-1 (casp1), 296 
interleukin-1beta (il1b), interleukin-15 (il15), interferon regulatory factor 1 (irf1), ifn1 297 
and ifn2, and major histocompatibility complex- class II (mhc-II) (Figure 7A). 298 
Interestingly, ifng (pMCV1.4-ifng – VHSV fish) showed a synergic induction of 299 
immune-related genes compared to pMCV1.4 – VHSV fish (Figure 7A):  il1b (from 300 
FC=6.5 only with virus to FC=17.96 with Ifng and virus), il15 (from FC=1.75 to 301 
FC=4.53), interleukin-17 (il17) (from FC=1.64 to FC=14.15), ifn1 (from FC=29.43 to 302 
FC= 3256) and ifn2 (from FC=5 to FC=52.36). On the other hand, ifng overexpression 303 
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also had a detrimental effect in the expression of macrophage receptor with collagenous 304 
structure (marco), csf1, nadph oxidase 1 (nox1) and mhc-II in VHSV-infected fish, 305 
significantly reducing their expression compared to the pMCV1.4 – VHSV individuals 306 
(Figure 7A). In order to discard the potential migration of macrophages to the site of 307 
injection of the expression plasmid pMCV1.4-ifng, the transcription of marco was 308 
analyzed in the muscle samples, but no significant differences were observed compared 309 
to the control individuals (data not shown). 310 
After A. salmonicida challenge, numerous genes were also overexpressed (csf1, asc, 311 
casp1, il1b, il17, irf1, and mhc-II) (Figure 7B). Strikingly, in this case, the expression of 312 
some genes which were potentiated by Ifng during a viral infection was found to be 313 
down-regulated by ifng overexpression: il1b (from FC=28.56 only with bacteria to 314 
FC=8.09 with Ifng and bacteria), il17 (from FC=5.82 to FC=0.97) and ifn1 (from 315 
FC=2.3 to FC=0.54), together with other genes such as casp1, irf1 and major 316 
histocompatibility complex- class I (mhc-I) (Figure 7B). On the contrary, marco and 317 
macrophage mannose receptor 1 (mrc1) were significantly more expressed in those 318 
individuals previously injected with pMCV1.4-ifng (Figure 7B). 319 
In order to facilitate the comprehension of all these results, a schematic representation is 320 
provided (Figure 7C). The first boxes indicate the effect of a VHSV or A. salmonicida 321 
challenge in the expression of the tested genes. The second part indicates the effect of 322 
the previous administration of Ifng in the gene modulation during a viral or bacterial 323 
infection compared to those individuals not receiving the expression plasmid.  324 
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 325 
Figure 7. Expression analysis of immune genes in head kidney samples 24 h after the infection with VHSV (A) or A. 326 
salmonicida (B) in fish previously injected with the empty plasmid (pMCV1.4) or the expression plasmid (pMCV1.4-327 
ifng). Fold-changes were calculated by dividing the normalized expression values for the infected turbot by the 328 
normalized expression values for the uninfected pMCV1.4- injected individuals (control group). ### 329 
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(0.0001<p<0.001), ## (0.001<p<0.01) and # (0.01<p<0.05) represent gene modulations due to the effect of the 330 
infection itself (e.g. pMCV1.4-VHSV and pMCV1.4-A. salmonicida vs. pMCV1.4). *** (0.0001<p<0.001), ** 331 
(0.001<p<0.01) and * (0.01<p<0.05) represent differences between individuals previously receiving the expression 332 
plasmid (pMCV1.4-ifng) or the empty plasmid (pMCV1.4) and then infected (C) Schematic representation of the 333 
significant modulations observed in this experiment. 334 
4. Discussion 335 
Since the first teleost ifng gene was detected in the fugu (Takifugu rubripes) genome 336 
several years ago [38] ifng genes were characterized in numerous fish species. However, 337 
the absence of sequences for this gene in turbot hindered its identification until now. 338 
The turbot (S. maximus) genome, recently sequenced [20], has led us to the first-time 339 
identification of an ifng gene in this flatfish. The additional fish type II IFN (ifngrel), 340 
mainly characterized in numerous cyprinid species [10,12,14,39], appears to be absent 341 
in turbot, as was observed in other teleosts. ifng gene encodes a protein composed of 342 
202 aa, and contains a 22 aa signal peptide on the N-terminus and a nuclear localization 343 
signal (NLS) near its C-terminus, which is needed for the translocation into the nucleus 344 
and the bioactivity of this molecule [40].  345 
Three GAS and one ISRE sequences were found on the promotor region of the turbot 346 
ifng, which indicate that this gene can be activated via the interferon-gamma- or type I 347 
IFNs-induced Jak-Stat signaling pathway [41]. Indeed, turbot ifng expression was 348 
significantly induced by the i.m. administration of the two expression plasmids 349 
encoding Ifn1 and Ifn2, two different type I IFNs. Agreeing with previous studies about 350 
the activity of turbot type I IFNs [4], Ifn1 showed a higher and broader activation of 351 
ifng transcription, whereas Ifn2 activity was localized to the site of injection. ifng was 352 
also overexpressed after pathogen challenge with both virus and bacteria. Type I IFNs 353 
are the main cytokines orchestrating the antiviral defense through the induction of 354 
numerous interferon-stimulated genes (ISGs) [6]. However, whereas type I IFNs are 355 
pivotal in acute infections, IFN-gamma also contributes to the defense against viruses, 356 
but especially during long-term infections [42]. Knockout murine models revealed that 357 
the absence of IFN-gamma or the corresponding receptors generates deficiencies in 358 
natural resistance to different viruses [43-47]. Deficiencies in the immune response 359 
were also observed against bacterial infections [48-52]. Therefore, IFN-gamma seems to 360 
be important in the correct resolution of both viral- and bacterial-caused diseases. 361 
Nevertheless, the injection of an expression plasmid encoding turbot Ifng was not able 362 
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to reduce the mortality induced by VHSV or A. salmonicida infections, although we 363 
cannot rule out that lower doses of pathogens could reveal any significant difference.   364 
Moreover, only csf1 gene was significantly up-regulated in head kidney 2 days after the 365 
administration of pMCV1.4-ifng. Similar results were observed in adult zebrafish 366 
injected with recombinant Ifng; this molecule had a weak effect on the expression of 367 
immune genes and did not reduce the mortality caused by bacterial (Streptococcus 368 
iniae) or viral (SVCV) infections [18]. Grayfer and Belosevic [53] hypothesized that 369 
this lack of response could be due to the fact that Ifng is bounded up by cells expressing 370 
only one interferon-gamma receptor (Ifngr1) and not both receptors (Ifngr1 and Ifngr2), 371 
indicating a localized nature of the zebrafish Ifng. The majority of experiments 372 
performed in mammals and fish using recombinant IFN-gamma were conducted in vitro 373 
and, in these cases, significant immune effects were observed, especially in 374 
macrophages and neutrophils [13,16,17,19,54-57]. Probably the immune effects of 375 
recombinant Ifng in vivo are more subtle and dependent on the doses and protocols of 376 
inoculation, among others.  377 
After infection with VHSV some immune genes were significantly higher expressed in 378 
those individuals previously inoculated with the ifng expression plasmid than in those 379 
injected with the empty plasmid. These genes corresponded to pro-inflammatory 380 
cytokines (il1b, il15, il17) and both type I IFNs (ifn1 and ifn2). Surprisingly, on the 381 
contrary, il1b, il17 and ifn1 (together with casp1, irf1 and mhc-I) were lower expressed 382 
after an A. salmonicida challenge in those individuals previously stimulated with 383 
pMCV1.4-ifng. Therefore, although pMCV1.4-ifng did not elicit a protective effect in 384 
VHSV- or Aeromonas-infected turbot, its i.m. injection was able to specifically 385 
modulate the expression of different pro-inflammatory cytokines and type I IFNs in an 386 
opposite way depending on the pathogen.  387 
Classically, IFN-gamma has been regarded as a pivotal pro-inflammatory cytokine in 388 
inflammation and autoimmune diseases [9]. However, during the last two decades 389 
numerous evidences supported the idea of a dual role of IFN-gamma genes in 390 
inflammation [8, 9], highlighting the complexity of the immune mechanisms in which 391 
this molecule is implicated. Although type I IFNS are the main anti-viral signaling 392 
molecules, IFN-gamma also seems to be essential in the resolution of viral diseases [43-393 
47]. The activity of IFN-gamma includes the activation of a subset of IFN-gamma 394 
inducible genes, such as the transcription factor IRF1 [58], which is able to activate type 395 
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I IFN gene promoters and induce type I IFN genes [59]. Therefore, in the case of VHSV 396 
infection, the effect of ifng overexpression could be expected, acting in synergy with the 397 
virus and potentiating the inflammation and expression of type I IFNs. Regarding the 398 
effect of IFN-gamma in bacterial infections, the observations conducted in murine 399 
models are contradictory, attributing to this protein a pro-inflammatory [60,61] or anti-400 
inflammatory role [62,63] depending on the bacteria and experimental design.  401 
MARCO and MRC1 are receptors typically expressed in macrophages and implicated in 402 
the clearance of pathogens [64-66]. The transcription of marco and mrc1 was 403 
significantly down-regulated after bacterial infection but restored in those fish also 404 
receiving the expression plasmid encoding Ifng. The increase in the transcription of 405 
marco and mrc1 by Ifng seems to indicate a positive effect in the macrophages activity 406 
during bacterial infection. In contrast, the opposite behavior was observed during 407 
VHSV infection, in which Ifng reduced the transcription of marco, csf1 and nox1. csf1 408 
is implicated in the proliferation of macrophages [67], and nox1 is an enzyme mediating 409 
the respiratory burst in macrophages and neutrophils, a potent microbicidal mechanism 410 
[68]. Therefore, the reduction in the expression of these genes could be reflecting that 411 
Ifng exerts a suppressive effect in the macrophages activity when the individuals are 412 
suffering a viral infection.  413 
It has been reported that macrophages are probably the target cells of the rhabdovirus 414 
infections, at least during the first stages of infection, and that they are destroyed 415 
through virus-induced pyroptosis [69,70]. Due to the effect of Ifng during VHSV 416 
infection (down-regulation of marco and csf1, and overexpression of pro-inflammatory 417 
genes), we thought about the possibility that Ifng was favoring the death of the 418 
macrophages. For that reason, we checked the transcriptomic modulation of asc and 419 
casp1, two genes encoding for key components of the pyroptosis process. However, no 420 
significant increases in the expression of both genes were observed in those turbot pre-421 
treated with pMCV1.4-ifng compared to the individuals injected with the empty 422 
plasmid. Therefore, Ifng could be directly modulating the expression of marco and csf1. 423 
It was reported that mutant mice deficient in MARCO (MARCO –/–) had lower 424 
morbidity and mortality caused by influenza pneumonia than wild-type mice because 425 
MARCO suppresses the early inflammatory response against the virus [71]. Therefore, 426 
if Ifng reduces the expression of marco in turbot during a viral infection, the higher 427 
level of pro-inflammatory cytokines could be due to the effect of Marco in the 428 
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inflammatory response. This is also in accordance with the activity of Ifng during the 429 
bacterial challenge, because marco was overexpressed in pre-treated fish compared to 430 
the individuals only inoculated with the bacteria, and the pro-inflammatory cytokines 431 
were down-regulated in this case. We hypothesize that marco could be directly 432 
modulated by Ifng and, as consequence, this can have an effect in the inflammation.  433 
The innate immune system’s recognition of pathogens is predominantly mediated by a 434 
limited range of genome-coded pattern recognition receptors (PRRs). PRRs are 435 
activated by the recognition of pathogen-associated molecular patterns (PAMPs), such 436 
as bacterial and fungal glycoproteins and lipopolysaccharides or viral components [2]. 437 
Once activated by the recognition of its specific ligand, PRRs initiate intracellular 438 
signaling cascades with the objective to produce an adequate response to the stimulus 439 
that activated them [72]. The specific inflammatory response is both dependent on the 440 
PAMP that was detected and the cell type that was activated, that is, viral PAMPs are 441 
recognized by different PRRs than those recognizing bacterial components and use 442 
different intracellular pathways that lead to the transcription of different inflammatory 443 
genes and the activation of different immune cell subsets [2]. This differential activation 444 
of the cellular immune response, together with the fact that each pathogen possesses 445 
preferences for its own target cells, culminates in a pathogen-specific immune response 446 
[73]. Although more research is needed, the dual role of Ifng that we demonstrate in this 447 
article could be due to the differential effect that this molecule exerts on the different 448 
already activated immune cell populations. 449 
 450 
5. Conclusions  451 
We can resume all these results into three main points: I) Ifng potentiated inflammation 452 
during viral infection, but it had anti-inflammatory effects during bacterial disease; II) 453 
Ifng administration had a synergic or detrimental effect in the transcription of type I 454 
IFNs depending on the pathogen; III) Ifng seemed to favor the expression of those 455 
genes directly related with the activity of macrophages in A. salmonicida-infected 456 
turbot, but the opposite effect was observed in VHSV-infected individuals.  457 
Further research is needed in order to elucidate these gene regulations, probably by 458 
using a model organism such as the zebrafish. Given that in this study viral and 459 
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bacterial infections were conducted in parallel, using the same experimental design and 460 
cohort of fish, this is the first time that the dual role of IFN-gamma has been clearly 461 
exposed.   462 
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FIGURE CAPTIONS 471 
Figure 1. (A) Nucleotide and amino acid sequence of turbot ifng. The predicted signal 472 
peptide is underlined, whereas the nuclear localization signal (NLS) is boxed. (B) 473 
Comparison of the predicted tertiary structure of turbot Ifng (color cartoon view) with 474 
human IFN-gamma (blue ribbon diagram). (C) Promotor region of turbot ifng gene 475 
showing three potential GAS and one ISRE sequences. 476 
Figure 2. Phylogenetic tree showing the evolutionary relationships between vertebrate 477 
IFN-gamma and IFN-gamma related proteins. Only nodal bootstrap values lower than 478 
95 are shown. 479 
Figure 3. Turbot ifng constitutive expression in different tissues obtained from healthy 480 
fish.  481 
Figure 4. (A) Induction of the expression of turbot ifng 2 days after the administration 482 
of the expression plasmids encoding both type I IFNs (pMCV1.4-ifn1 or pMCV1.4-483 
ifn2) in muscle (site of injection) and head kidney or (B) at different sampling points 484 
after a VHSV or A. salmonicida challenge in head kidney samples.  Significant 485 
differences are displayed as ** (0.001<p<0.01), * (0.01<p<0.05). 486 
Figure 5. (A) Expression of turbot ifng in muscle (site of injection) 2 days after the 487 
administration of pMCV1.4-ifng compared to those individuals receiving the empty 488 
plasmid pMCV1.4. (B) Cumulative mortality (%) after a VHSV challenge in turbot 489 
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previously injected in muscle with PBS, pMCV1.4 or pMCV1.4-ifng, and VHSV 490 
detection by qPCR in head kidney samples 24 h after infection. (C) Cumulative 491 
mortality (%) after an A. salmonicida challenge in turbot previously injected in muscle 492 
with PBS, pMCV1.4 or pMCV1.4-ifng, and bacteria detection by qPCR in head kidney 493 
samples 24 h after infection.  494 
Figure 6. Expression analysis of several immune genes in head kidney samples 2 days 495 
after the i.m. injection of the expression plasmid pMCV1.4-ifng. Fold-changes were 496 
calculated by dividing the normalized expression values for the pMCV1.4-ifng 497 
inoculated turbot by the normalized expression values for the pMCV1.4- injected 498 
individuals (control group). Significant differences were displayed as * (p<0.05). 499 
Figure 7. Expression analysis of immune genes in head kidney samples 24 h after the 500 
infection with VHSV (A) or A. salmonicida (B) in fish previously injected with the 501 
empty plasmid (pMCV1.4) or the expression plasmid (pMCV1.4-ifng). Fold-changes 502 
were calculated by dividing the normalized expression values for the infected turbot by 503 
the normalized expression values for the uninfected pMCV1.4- injected individuals 504 
(control group). ### (0.0001<p<0.001), ## (0.001<p<0.01) and # (0.01<p<0.05) 505 
represent gene modulations due to the effect of the infection itself (e.g. pMCV1.4-506 
VHSV and pMCV1.4-A. salmonicida vs. pMCV1.4). *** (0.0001<p<0.001), ** 507 
(0.001<p<0.01) and * (0.01<p<0.05) represent differences between individuals 508 
previously receiving the expression plasmid (pMCV1.4-ifng) or the empty plasmid 509 
(pMCV1.4) and then infected (C) Schematic representation of the significant 510 
modulations observed in this experiment. 511 
 512 
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